Eric W. Refsland, Ph.D.
Affiliations: | 2014 | Biochemistry, Molecular Bio, and Biophysics | University of Minnesota, Twin Cities, Minneapolis, MN |
Area:
Molecular Biology, Virology Biology, Cell Biology, OncologyGoogle:
"Eric Refsland"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Reuben S. Harris | grad student | 2014 | UMN | |
| (Determination of the Endogenous HIV-Restrictive APOBEC3 Repertoire.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Blazkova J, Refsland EW, Clarridge KE, et al. (2019) Glycan-dependent HIV-specific neutralizing antibodies bind to cells of uninfected individuals. The Journal of Clinical Investigation |
| Clarridge KE, Blazkova J, Einkauf K, et al. (2018) Effect of analytical treatment interruption and reinitiation of antiretroviral therapy on HIV reservoirs and immunologic parameters in infected individuals. Plos Pathogens. 14: e1006792 |
| Refsland EW, Hultquist JF, Luengas EM, et al. (2014) Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity. Plos Genetics. 10: e1004761 |
| Refsland EW, Harris RS. (2013) The APOBEC3 family of retroelement restriction factors. Current Topics in Microbiology and Immunology. 371: 1-27 |
| Burns MB, Lackey L, Carpenter MA, et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 494: 366-70 |
| Burns MB, Lackey L, Carpenter MA, et al. (2013) Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer Nature. 502: 580-580 |
| Refsland EW, Hultquist JF, Harris RS. (2012) Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n. Plos Pathogens. 8: e1002800 |
| Hultquist JF, Lengyel JA, Refsland EW, et al. (2011) Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. Journal of Virology. 85: 11220-34 |
| Burns MB, Lackey L, Land A, et al. (2011) Abstract LB-193: APOBEC3 catalyzed genomic mutations in breast cancer Cancer Research. 71 |
| Refsland EW, Stenglein MD, Shindo K, et al. (2010) Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Research. 38: 4274-84 |